Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Drug Resistance”

160 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 160 results

Not applicableUnknownNCT02306577
What this trial is testing

STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)

Who this might be right for
HIVIllicit Drug User
Vancouver Infectious Diseases Centre 30
Not applicableLooking for participantsNCT06762054
What this trial is testing

Investigating the Optimal Management of Dolutegravir Resistance

Who this might be right for
HIV-1-infection
University of Nairobi 6,600
Post-approval studies (Phase 4)Study completedNCT00084136
What this trial is testing

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 1,571
Not applicableStudy completedNCT00279331
What this trial is testing

Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador

Who this might be right for
HIV InfectionsSyphilisSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 2,608
Not applicableStudy completedNCT01976715
What this trial is testing

Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy

Who this might be right for
Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAIDS Virus+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 26
Large-scale testing (Phase 3)Study completedNCT01061593
What this trial is testing

Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV

Who this might be right for
TuberculosisHIV
Lisichansk Regional Tuberculosis Dispensary 269
Not applicableStudy completedNCT00001092
What this trial is testing

The Biology of HIV Transmission

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableUnknownNCT05071573
What this trial is testing

Optimised Electronic Patient Records to Improve Clinical Monitoring of HIV-positive Patients in Rural South Africa

Who this might be right for
HIV Infections
University of Sussex 1,500
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Post-approval studies (Phase 4)UnknownNCT01201239
What this trial is testing

Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients

Who this might be right for
HIV
Shanghai Public Health Clinical Center 50
Large-scale testing (Phase 3)WithdrawnNCT00011128
What this trial is testing

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableWithdrawnNCT03928834
What this trial is testing

Sustainable Adherence and Prevention of HIV Drug Resistance in Adolescents

Who this might be right for
Medication AdherenceHIV Drug Resistance
University of Zimbabwe
Not applicableStudy completedNCT02689895
What this trial is testing

Etiology of Treatment Failure in HIV Positive Children and Adolescents on Boosted Protease Inhibitor-based Regimens

Who this might be right for
HIV
University of Zimbabwe 50
Testing effectiveness (Phase 2)Study completedNCT00088309
What this trial is testing

Effect of Tenofovir DF on Bone Metabolism in Children

Who this might be right for
HIV Infections
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Study completedNCT00293254
What this trial is testing

Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 351
Testing effectiveness (Phase 2)UnknownNCT04560569
What this trial is testing

Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection

Who this might be right for
HIV/AIDS
Frontier Biotechnologies Inc. 20
Not applicableUnknownNCT00102934
What this trial is testing

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Post-approval studies (Phase 4)UnknownNCT01230580
What this trial is testing

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

Who this might be right for
HIV InfectionAcquired Immunodeficiency Syndrome
Medical Research Council 587
Testing effectiveness (Phase 2)Study completedNCT00000747
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableLooking for participantsNCT07643948
What this trial is testing

Impacts of HIV Treatment Regimens on Archived Drug Resistance

Who this might be right for
HIV -1 InfectionAntiretroviral TherapyDrug Resistance, Microbial
Chinese University of Hong Kong 420
Load More Results